ArticleTherapeutic advances in neurological disorders2026

Use of subcutaneous natalizumab in routine care - Final results of a non-interventional, observational study (SISTER) in Germany and Austria.

Ralf Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.